IGA NEPHROPATHY

Clinical trials for IGA NEPHROPATHY explained in plain language.

Never miss a new study

Get alerted when new IGA NEPHROPATHY trials appear

Sign up with your email to follow new studies for IGA NEPHROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 14 Not yet recruiting 6 Not yet finished but already full! 4 Completed 12 Terminated 1

Kidney disease drug trial halted midway

Disease control Terminated

This study tested a drug called OMS721 for people with IgA nephropathy, a kidney disease that can lead to kidney failure. The goal was to see if the drug could reduce protein in the urine, a sign of kidney damage. The trial was stopped early, so results are limited.

Matched conditions: IGA NEPHROPATHY

Phase: PHASE3 • Sponsor: Omeros Corporation • Aim: Disease control

Last updated Jun 27, 2026 08:03 UTC

IGA NEPHROPATHY

Get alerted when new IGA NEPHROPATHY trials appear

Kidney disease drug trial halted midway